What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

ECG Interpretation: Everything You Need to Know to Understand and In…

Houston Methodist DeBakey Heart and Vascular Center

A. Dave

EHRA 2024: Ongoing Clinical Investigations with Cardiac Contractilit…

CCM® Therapy

N. Varma

Implementation of Drug Therapies for Heart Failure with Reduced Ejec…

Michigan Medicine

J. Golbus

EHRA 2024: Real-World Experience with Cardiac Contractility Modulati…

CCM® Therapy

J. Kuschyk

EHRA 2024: Cardiac Contractility Modulation: Innovative Therapy for …

CCM® Therapy

V. Reddy, N. Varma, K. Kuck, J. Kuschyk, N. Aspromonte

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

APOL1 Controversies Conference Plenary: APOL1 Pathophysiology

KDIGO

D. Friedman

EADV 2024 Insights: Calciphylaxis

EADV 2024 Insights

C. Erfurt-Berge

A New Paradigm: Rethinking Hypherphosphatemia Management

Icahn School of Medicine at Mount Sinai

D. Spiegel

KDIGO Scientific Symposium on the Impact of Viral Infection and the …

KDIGO

S. Chadban, U. Huynh-Do, M. Jadoul, D. Kumar

Cancer Before Solid Organ Transplant

Fred Hutchinson Cancer Center

C. Blosser

Social Determinants of Health for Cardiovascular Kidney Metabolic Sy…

Kibret Enyew Belay

AHA 2024 Insights: MayaRED - Revolutionizing Hospital Discharge Thro…

AHA 2024 Insights

A. Mohammadi